Saltar al contenido principal
TransparenciaAlgunas páginas de este sitio contienen enlaces de afiliados; podemos ganar una comisión si compra a través de ellos. Nuestras puntuaciones y clasificaciones siguen nuestra metodología publicada; las comisiones no influyen en ellas. Lea nuestra metodología →
HierbaDosis clínica · 100–200mg/day (Pycnogenol or equivalent standardised extract)Inicio de acción · The cognitive studies ran 8–12 weeks

Maritime Pine Bark Extract

A 2014 Pycnogenol study (Belcaro et al.) in healthy professionals aged 35–55 reported small but significant cognitive improvements and a 30.4% drop in plasma free radicals after 12 weeks at 150mg/day — but it was a non-randomized product-evaluation registry study, not an RCT. A 2011 controlled (non-randomized) study in students (Luzzi et al.) reported better attention, memory and exam scores over 8 weeks. Both come from the same Irvine3 Labs / Chieti-Pescara author group, which has published numerous Pycnogenol studies; Pycnogenol is a Horphag Research trademark, and these trials are widely reported as industry-supported, though no sponsor is disclosed in the abstracts. The independent 2020 Cochrane review rated the evidence for every pine bark outcome it assessed as very low certainty. A 2025 network meta-analysis ranked Pycnogenol highly for mild cognitive impairment but cautioned about heterogeneity.

Por el equipo editorial de The Nootropic LabActualizado 8 min de lectura✓ Datos verificados

Evidencia revisada el

Mecanismo de acción

Maritime Pine Bark Extract (Pinus pinaster) contains proanthocyanidins — potent polyphenol antioxidants that cross the blood-brain barrier. It works via three pathways: (1) stimulating endothelial nitric oxide synthase (eNOS) to increase cerebral blood flow via vasodilation; (2) scavenging reactive oxygen species to protect neuronal membranes; (3) modulating NF-κB inflammatory signalling to reduce neuroinflammation. Pycnogenol is a branded form.

Resumen de evidencia clínica

A 2014 Pycnogenol study (Belcaro et al.) in healthy professionals aged 35–55 reported small but significant cognitive improvements and a 30.4% drop in plasma free radicals after 12 weeks at 150mg/day — but it was a non-randomized product-evaluation registry study, not an RCT. A 2011 controlled (non-randomized) study in students (Luzzi et al.) reported better attention, memory and exam scores over 8 weeks. Both come from the same Irvine3 Labs / Chieti-Pescara author group, which has published numerous Pycnogenol studies; Pycnogenol is a Horphag Research trademark, and these trials are widely reported as industry-supported, though no sponsor is disclosed in the abstracts. The independent 2020 Cochrane review rated the evidence for every pine bark outcome it assessed as very low certainty. A 2025 network meta-analysis ranked Pycnogenol highly for mild cognitive impairment but cautioned about heterogeneity.

Matriz de efectos en humanos

Basado solo en ensayos clínicos en humanos. Se excluyen los datos en animales e in vitro.

EfectoEvidenciaMagnitudEstudios
Attention & Focus preliminar
Pequeño
3
Oxidative Stress Reduction preliminar
Moderado
1
Cerebral Blood Flow moderada
Pequeño
—
Memory preliminar
Pequeño
2

Clave de evidencia: Sólida = varios ECA consistentes · Moderada = ECA más pequeños o menos numerosos · Preliminar = ensayos iniciales o n pequeño · Mixta = resultados contradictorios

Beneficios documentados

  • Lower oxidative stress markers
  • Attention and focus (preliminary, non-randomized studies)
  • Antioxidant activity

Efectos secundarios y precauciones

  • Generally well tolerated, though adverse-event reporting was inconsistent across trials (Cochrane 2020)
  • Rare: mild GI discomfort
  • Headache (uncommon)
  • Immunosuppressants: possible interaction, not confirmed by clinical reports — ask your doctor

Cómo tomarlo

Dosis100–200mg/day of standardised extract (65-75% proanthocyanidins)
MomentoMorning with breakfast. Can be split into 2 doses for sustained antioxidant coverage.
Con comidaTake with food for better absorption and reduced GI risk. Fat is not required but a meal is recommended.
FormasCapsule is standard. Pycnogenol is a branded extract; it is the extract used in the studies we cite (Belcaro 2014; Luzzi 2011). Generic pine bark extracts vary widely in proanthocyanidin content — check standardisation percentage.

Recomendaciones de combinación

Ingredientes que se combinan bien con Maritime Pine Bark Extract y por qué.

Citicoline provides cholinergic focus; Pine Bark provides blood flow and antioxidant support. Together they form the core of Performance Lab Mind — a minimal, evidence-based focus stack.

Pine Bark supports cerebral blood flow (delivery); Tyrosine supports catecholamine synthesis (production). Complementary supply-side + demand-side pairing.

Pine Bark protects neuronal membranes from oxidative damage; DHA provides the structural fatty acid for those membranes. Protective + structural combination.

Preguntas frecuentes

What is Pycnogenol and is it worth the premium?

Pycnogenol is a patented extract of French Maritime Pine Bark (Pinus pinaster) standardised to 65-75% proanthocyanidins with a specific manufacturing process. It is the extract used in the studies we cite (Belcaro 2014; Luzzi 2011); we found no trial comparing it with generic pine bark extract. Generic pine bark extracts may vary in composition. To match that evidence, choose Pycnogenol.

How does Maritime Pine Bark compare to Ginkgo Biloba?

Both improve cerebral blood flow but via different mechanisms: Ginkgo inhibits platelet-activating factor; Pine Bark stimulates nitric oxide. Pine Bark has stronger antioxidant activity; Ginkgo has a larger evidence base for cognitive decline. No trial has tested the combination, and ginkgo raises bleeding risk with blood thinners.

Can I take Pine Bark Extract long-term?

The pooled trials ran from 4 weeks to 6 months, and the Cochrane review notes adverse events were reported inconsistently, so the absence of reported harm is not proof of long-term safety. No cycling protocol has been tested. Check with your doctor if you take immunosuppressants.

Why is the dose in Performance Lab Mind only 75mg?

Performance Lab Mind uses 75mg Maritime Pine Bark — below the 100-200mg clinical dose on this page (the Belcaro 2014 study we cite used 150mg/day). It sits in a multi-ingredient formula with Citicoline and Tyrosine, but it is still underdosed relative to the standalone evidence.

Principales stacks que contienen Maritime Pine Bark Extract

Maritime Pine Bark Extract en América Latina

Productos disponibles en América Latina

ANVISA / COFEPRIS / INVIMA

Nota regulatoria

Esta página es contenido editorial con fines educativos y no constituye consejo médico. Los suplementos alimenticios están regulados por agencias nacionales: la Agência Nacional de Vigilância Sanitária (ANVISA) en Brasil bajo RDC 243/2018, la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) en México, y el Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) en Colombia. En Argentina, la Disposición 2105/2022 de la Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) prohíbe siete productos concretos de las marcas Newmind y PURENOOTROPICS (Noopept, F-Phenibut y Bacopa) — no recomendamos productos con Noopept ni F-Phenibut a lectores en Argentina. Aviso para lectores en Brasil: el 2 de julio de 2026, ANVISA informó que algunos péptidos inyectables promocionados en internet, entre ellos GHK-Cu, BPC-157, TB-500, CJC-1295 e ipamorelin, no están regularizados en ninguna categoría (alimento, medicamento, cosmético ni suplemento alimentario) y son ilegales para cualquier uso en salud, incluido el estético. No enlazamos ni recomendamos proveedores que realicen envíos de formulaciones inyectables a Brasil. Consulte siempre a un profesional de la salud calificado antes de comenzar cualquier suplemento. / This page is editorial and not medical advice. Supplements are regulated by national agencies: the Agência Nacional de Vigilância Sanitária (ANVISA) in Brazil, the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico, and the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) in Colombia. In Argentina, ANMAT Disposition 2105/2022 prohibits seven specific products of the Newmind and PURENOOTROPICS brands (Noopept, F-Phenibut and Bacopa) — we do not recommend products containing Noopept or F-Phenibut to Argentine readers. Brazil notice: on 2 July 2026, ANVISA stated that some injectable peptides promoted online, including GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin, are not regularised in any category (food, medicine, cosmetic or food supplement) and are illegal for any health use, including aesthetic use. We do not link to or recommend vendors that ship injectable formulations to Brazil. Consult a qualified healthcare professional before starting any supplement.

Fuentes (5)ampliar